What is Apical Instruments?
Apical Instruments is a prominent innovator within the medical device industry, specializing in the critical areas of biotechnology and semiconductor needs. The company provides end-to-end services, guiding clients from the initial proof of concept stages all the way to final production. Apical Instruments places a strong emphasis on regulatory compliance, adhering strictly to both FDA and international standards. Their robust design control processes, aligned with ISO 13485, ensure the consistent delivery of high-quality products within established timelines. The company's core mission is to act as a strategic partner, empowering clients to transform their innovative ideas into tangible realities through comprehensive support across the entire product development lifecycle.
How much funding has Apical Instruments raised?
Apical Instruments has raised a total of $379K across 2 funding rounds:
Debt
$150K
Debt
$229K
Debt (2020): $150K with participation from PPP
Debt (2021): $229K led by PPP
Key Investors in Apical Instruments
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Apical Instruments?
The recent strategic investment in Apical Instruments signals a pivotal moment for the company, likely indicating a transition into a scaling phase. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and potentially expand market reach. Given the company's focus on FDA and international compliance, future growth may involve navigating complex regulatory pathways for new product introductions or seeking strategic partnerships to broaden its technological portfolio. The company's commitment to quality and its comprehensive service model position it for sustained growth and influence within the medical technology landscape.
See full Apical Instruments company page
